Skip to main content
. 2018 May 18;12:861–868. doi: 10.2147/PPA.S162744

Table 1.

General characteristics of the children before treatment

Characteristics Conventional nebulization (N=35) Smart nebulization (N=30) Total N=65 P-value
Age (months, mean ± SD) 38.54±12.08 37.17±11.68 37.91±11.83 0.644
Gender, N (%) 0.487
 Male 25 (71.43) 19 (63.33) 44 (67.69)
 Female 10 (28.57) 11 (36.67) 21 (32.31)
Allergen, N (%) 0.767
 Mite 29 (82.86) 24 (80.00) 53 (81.54)
 Unknown 6 (17.14) 6 (20.00) 12 (18.46)
Eczema, N (%) 0.745
 No 7 (20.00) 7 (23.33) 14 (21.54)
 Yes 28 (80.00) 23 (76.67) 51 (78.46)
Rhinitis, N (%) 0.841
 No 23 (65.71) 19 (63.33) 42 (64.62)
 Yes 12 (34.29) 11 (36.67) 23 (35.38)
Parent rhinitis, N (%) 0.749
 No 22 (62.86) 20 (66.67) 42 (64.62)
 Yes 13 (37.14) 10 (33.33) 23 (35.38)
Parent asthma, N (%) 0.931
 No 26 (74.29) 22 (73.33) 48 (73.85)
 Yes 9 (25.71) 8 (26.67) 17 (26.15)
Serum IgE, N (%) 0.628
 0 6 (17.14) 8 (26.67) 14 (21.54)
 1 7 (20.00) 6 (20.00) 13 (20.00)
 2 22 (62.86) 16 (53.33) 38 (58.46)